1303PD Nivolumab in previously treated patients with metastatic squamous NSCLC: results of a European single-arm, phase 2 trial (CheckMate 171) including patients aged >= 70 years and with poor performance status.
Authors
Popat, SArdizzoni, A
Ciuleanu, T
Dols, M
Laktionov, K
Szilasi, M
Califano, Raffaele
Costa, E
Griffiths, R
Paz-Ares, L
Szczylik, C
Corral, J
Isla, D
Jassem, J
Appel, W
Van Meerbeeck, J
Wolf, J
Jiang, J
Molife, L
Font, E
Affiliation
Medical Oncology, Royal Marsden Hospital, SW3 6JJ - LondonIssue Date
2017